Medexus Pharmaceuticals Operating Income Over Time
| MDP Stock | 2.86 0.12 4.38% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Medexus Pharmaceuticals Performance and Medexus Pharmaceuticals Correlation. Medexus |
Cross Equities Operating Income Analysis
Compare Medexus Pharmaceuticals and related stocks such as Decibel Cannabis, and Cardiol Therapeutics Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DB | (75.8 K) | (1.4 M) | (122.1 K) | (157.8 K) | (150.3 K) | (96.2 K) | (28.7 K) | (15.8 K) | (4.5 M) | (3.6 M) | (5.4 M) | 6 M | (714 K) | 5.4 M | 2.6 M | 3 M | 3.2 M |
| CRDL | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (7.5 M) | (13.6 M) | (20.6 M) | (45.5 M) | (50.3 M) | (29.8 M) | (40.3 M) | (36.2 M) | (38.1 M) |
Medexus Pharmaceuticals and related stocks such as Decibel Cannabis, and Cardiol Therapeutics Operating Income description
Operating Income is the amount of profit realized from Medexus Pharmaceuticals operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Medexus Pharmaceuticals is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Medexus Pharmaceuticals | MDP |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 10 King Street |
| Exchange | Toronto Exchange |
null 2.86
Other Information on Investing in Medexus Stock
Medexus Pharmaceuticals financial ratios help investors to determine whether Medexus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medexus with respect to the benefits of owning Medexus Pharmaceuticals security.